| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | VCYT Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 5,032 | $42.89 | $215,833.55 | -10.6% | -22.0% | +10.4% | |
| Nov 26, 2024 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 5,000 | $25.00 | $125,000.00 | -1.5% | -14.9% | -29.1% | |
| Nov 26, 2024 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 4,000 | $166.34 | $665,375.96 | -0.8% | -5.9% | +40.9% | |
| Nov 26, 2024 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 34,688 | $236.93 | $8,218,556.67 | -53.3% | -10.8% | -3.4% | |
| Nov 25, 2024 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 497 | $18.26 | $9,074.87 | - | -8.6% | +68.3% | |
| Nov 25, 2024 | RDNT Radnet, Inc. | Katz David Jeffrey48 | EVP And Chief Legal Officer | Sell | 12,300 | $81.65 | $1,004,252.10 | -8.6% | -26.1% | +1.8% | |
| Nov 25, 2024 | FLGT Fulgent Genetics, Inc. | Hsieh Ming | Chief Executive Officer | Sell | 2,227 | $18.26 | $40,663.46 | -0.3% | -8.6% | +68.3% | |
| Nov 25, 2024 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 689 | $18.26 | $12,580.66 | -0.2% | -8.6% | +68.3% | |
| Nov 25, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 789 | $44.20 | $34,870.64 | -1.7% | -11.4% | -33.0% | |
| Nov 25, 2024 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 6,757 | $22.17 | $149,828.81 | -1.2% | -11.4% | -25.8% | |
| Nov 22, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.59 | $159,000.00 | - | +5.7% | -16.5% | |
| Nov 22, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 22,000 | $74.81 | $1,645,810.27 | -6.4% | +29.1% | +86.2% | |
| Nov 21, 2024 | BDSX Biodesix Inc | Kennedy Lawrence T. Jr | - | Buy | 35,000 | $1.16 | $40,561.50 | +0.3% | -21.2% | -71.5% | |
| Nov 21, 2024 | BDSX Biodesix Inc | Schuler Jack W45 | - | Buy | 100,000 | $1.23 | $122,840.00 | +0.3% | -21.2% | -71.5% | |
| Nov 20, 2024 | XGN Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% Owner | Sell | 200,000 | $3.30 | $660,040.00 | -8.7% | -10.4% | +85.0% | |
| Nov 20, 2024 | BDSX Biodesix Inc | Schuler Jack W45 | - | Buy | 200,000 | $1.17 | $234,000.00 | +0.6% | -18.5% | -72.6% | |
| Nov 20, 2024 | WGS Genedx Holdings Corp. | Ryan Jason65 | Director | Sell | 47,000 | $70.57 | $3,316,879.80 | -36.1% | +62.5% | +93.3% | |
| Nov 19, 2024 | RDNT Radnet, Inc. | Jayanathan Ranjan | Chief Information Officer | Sell | 38,557 | $80.00 | $3,084,560.00 | -16.7% | -23.0% | +0.6% | |
| Nov 19, 2024 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 9,682 | $159.98 | $1,548,930.73 | -31.0% | +4.5% | +34.7% | |
| Nov 19, 2024 | VCYT Veracyte, Inc. | Eastham Karin67 | Director | Sell | 14,731 | $38.34 | $564,768.40 | -15.8% | +3.2% | +2.0% | |
| Nov 18, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 921 | $3.79 | $3,490.59 | -0.7% | +68.2% | +112.3% | |
| Nov 18, 2024 | GRAL Grail, Inc. | Freidin Aaron | Chief Financial Officer | Sell | 30,452 | $14.02 | $426,937.04 | -10.2% | +236.6% | +481.9% | |
| Nov 18, 2024 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 7,000 | $29.25 | $204,722.00 | -28.3% | +66.7% | +230.0% | |
| Nov 18, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 1,307 | $3.79 | $4,953.53 | -0.7% | +68.2% | +112.3% | |
| Nov 18, 2024 | PSNL Personalis, Inc. | Moore Stephen Michael52 | SVP And Chief Legal Officer | Sell | 1,693 | $3.79 | $6,416.47 | -2.5% | +68.2% | +112.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.